Results for leprosy. Search took 0.16 seconds.
FDA Approves Thalomid For Multipple Myeloma Therapy
in The Biotech Weblog, on May 30, 2006
Thalomid (generic: thalidomide) is a drug manufactured by Celgene, Inc , for the treatment of certain symptoms associated with Erythema Nodosum Leprosum (ENL) . It is an inhibitor of tumor necrosis factor alpha , and is the best known agent for short-term treatment of ENL skin manifestation...




